Photronics, Inc. (PLAB) | The Buildout — AI Infrastructure
The Verdict
Photronics makes photomasks, the quartz or glass plates carrying microscopic circuit images that chipmakers and display makers use to print each layer of a design. Every new chip design and every new node needs a fresh set of masks, so the company sits upstream of chip production rather than inside it. AI demand reaches it indirectly, through leading-edge logic and memory designs and advanced packaging that require high-end masks — management calls that a multiyear opportunity. The catch is how orders arrive: a mask order is triggered when a customer releases a design, not when a fab runs wafers, and the company has limited visibility into that timing.
| Market Cap | — |
| Revenue (TTM) | $867M |
| Revenue Growth | +1.2% |
| EBITDA Margin (TTM) | 31.6% |
| Net Cash | $669M |
| Earnings Beats | 5 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- High-end IC set a record 44% of the IC line in Q3 FY2026, up from 38% in Q2, and high-end IC dollars grew roughly 20% sequentially on about 3% total revenue growth.
- Q3 revenue of $216M came in above the high end of the $207M-$215M guide, with operating margin of 21% against 18%-20% guided and non-GAAP diluted EPS of $0.50 against $0.39-$0.45.
- Operating cash flow was $76M, or 35% of revenue, up from $47M, or 22% of revenue, in Q2.
- Cash and short-term investments were $673M at Q3, with total debt of $3.9M — though $504M of that cash sits inside joint ventures in which the company holds a 50.01% interest.
- Expansion milestones are on schedule: Allen's initial U.S. revenue is targeted for the quarter just reported, Korea's 8-nanometer capability is on track for initial revenue by the end of fiscal 2027, and the most advanced FPD writer entered mass production in Q3.
What We’re Watching
- Q4 guidance was widened to a $20M range from $8M; management cites tight fab capacity, high memory costs and geopolitical conditions, and says the conditions present in Q2 "still largely remain." High-end mask sets carry far higher ASPs and deliver in days or weeks, so a handful of orders can move a quarter.
- FY2026 CapEx guidance was cut to $255M-$305M from $330M on the cadence of orders and vendor delivery, with unspent amounts expected to carry into FY2027 and the end-of-life tool peak now possibly falling in fiscal 2027 rather than 2026.
- Allen's first U.S. revenue was targeted for the quarter just ended — the most re-promised, most specific item on the record, and a credibility test at its stated deadline.
- A securities class action covers the period December 10, 2025 to May 27, 2026, with a lead-plaintiff deadline of September 4, 2026. All items remain allegations, not findings.
The Q3 quarter strengthened the mix half of the case: high-end IC hit a record share, revenue beat the high end of guidance, and operating cash flow jumped to 35% of revenue. The visibility half weakened: the Q4 band widened from $8M to $20M, FY2026 CapEx guidance was cut, and management said conditions from Q2 largely remain. The open question is whether the Q2 headwinds were genuinely temporary, as management framed them, or whether design-release visibility has reset lower — and the widening guidance band is management's own admission that it does not yet know.
Earnings Beat
Photronics reported FY2026 Q3 revenue of $216M, up about 3% year over year and sequentially, and above the high end of its $207M-$215M guidance. Gross margin was 33%, recovering from 31.3% in Q2 on product mix, higher revenue and operating leverage, and operating margin was 21% against guidance of 18%-20%. High-end IC reached a record 44% of the $155M IC line. Operating cash flow was $76M, or 35% of revenue, up from $47M in Q2. Non-GAAP diluted EPS of $0.50 exceeded the guided $0.39-$0.45.
| Metric | Q3 FY2026 | Q2 FY2026 | Q3 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $216M | $210M | $210M | +2.7% |
| Gross margin | 33.2% | 31.3% | 33.7% | -50bps |
| EBITDA | $66M | $62M | $67M | −0.7% |
| EPS | $0.49 | $0.54 | $0.38 | +30.3% |
| High-end IC mix (% of IC revenue) | 44% | 38% | n/a | — |
| Operating cash flow % of revenue | 35% | 22% | n/a | — |
Node migration and a sequential improvement in high-end business conditions benefited our high-end IC business, which recorded a record 44% of IC's $155 million in revenue.— George Macricostas, CEO, 2026-08-26
Management tone: Between the Q2 call (dated 2026-06-28 in the source) and the Q3 call (2026-08-26), management recognized the recovery of delayed design releases but grew more cautious about visibility. The Q3 revenue guide was $8M wide; the Q4 guide was widened to $20M. Management cut FY2026 CapEx guidance and said the end-of-life tool peak may fall in fiscal 2027 instead of 2026. Executives described the outlook as potentially "choppier, less predictable" and said visibility is "even more limited than it has been in the past." On the Q2 call they had said there were "very little levers" to pull because most of the cost base is fixed.
Management Guidance
For fiscal Q4 2026, management guides revenue of $207M-$227M, operating margin of 19%-24%, and non-GAAP diluted EPS of $0.40-$0.56 — all widened from the prior quarter's ranges. The stated reason is that tight fab capacity, memory costs and geopolitical conditions make the timing of design releases more uncertain. FY2026 CapEx guidance was cut to $255M-$305M from $330M because of the cadence of orders and vendor delivery of certain high-value tools; management says the projects and timelines behind the original $330M are unchanged, and that spending shifting beyond this fiscal year would carry into fiscal 2027. FY2027 CapEx guidance will be provided during the fiscal Q4 earnings release in December.
Trajectory
Revenue has been choppy: $225.1M in Q1 FY2026, $209.9M in Q2 and $216.0M in Q3. Gross margin fell from 35.0% in Q1 to 31.3% in Q2 and recovered to 33.2% in Q3 — still below the 33.7% recorded in Q3 FY2025 and well below the 38% gross margins booked in fiscal 2022 quarters. EBITDA margin followed the same path: 33.1%, then 29.6%, then 30.8%, and 31.6% on a trailing-twelve-month basis. Management attributes the Q2 drop to delayed design releases and higher labor, material and manufacturing costs, and the Q3 recovery to those delayed releases arriving alongside better mix. The leverage is large in both directions: about 91% of incremental revenue from Q2 to Q3 dropped through to gross profit, and about 52% reached operating income.
The Model
The model projects FY+1 revenue of 924M and EBITDA of 296M (32.0%), then FY+2 revenue of 985M and EBITDA of 322M (32.7%). That compares with trailing-twelve-month revenue of 866.8M and EBITDA of 274.0M at a 31.6% margin. The near-term case rests on high-end IC mix, FPD running near all-time highs, and the first U.S. revenue from the Allen expansion; FY+2 assumes Allen contributes meaningfully and Korea's 8-nanometer expansion begins generating revenue, which management has said land in fiscal 2027 and beyond.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $849M | $924M | $985M |
| YoY Growth | — | +8.8% | +6.6% |
| EBITDA | $286M | $296M | $322M |
| EBITDA Margin | 33.7% | 32.0% | 32.7% |
Projections are the median of 5 independent model runs. The model’s revenue sits 3.5% above analyst consensus.
For fiscal Q4 2026, management guides revenue of $207M-$227M, operating margin of 19%-24%, and non-GAAP diluted EPS of $0.40-$0.56 — all widened from the prior quarter's ranges. The stated reason is that tight fab capacity, memory costs and geopolitical conditions make the timing of design releases more uncertain. FY2026 CapEx guidance was cut to $255M-$305M from $330M because of the cadence of orders and vendor delivery of certain high-value tools; management says the projects and timelines behind the original $330M are unchanged, and that spending shifting beyond this fiscal year would carry into fiscal 2027. FY2027 CapEx guidance will be provided during the fiscal Q4 earnings release in December.
What Could Go Right — and Wrong
- Q4 revenue lands mid-to-high in the $207M-$227M band and operating margin lands at or above the midpoint of 19%-24%, validating the Q3 recovery as a trend rather than a one-quarter catch-up of delayed orders.
- Allen's initial U.S. revenue is confirmed for the quarter just ended, and U.S. revenue leads all geographies in fiscal 2027 as management expects.
- High-end IC dollars climb back above Q1 FY2026's $71.3M while the mix holds near 44% of IC, making the shift a volume-and-mix story rather than a denominator effect from shrinking mainstream revenue.
- FY2027 CapEx guidance in December confirms carryover rather than cancellation, keeping the Allen and Korea schedules intact and the fiscal 2027 revenue contribution on plan.
- A customer partnership or co-funding structure is disclosed for the expansion or EUV program, or FPD holds near all-time highs as G8.6 AMOLED orders keep broadening.
- Q4 revenue lands at the low end of the band with operating margin at 19%, confirming that the conditions present in Q2 still dominate and that Q3 was a catch-up quarter.
- High-end IC mix relapses toward the mid-30s — Q2's level — signalling renewed delays in customer design releases.
- Gross margin fails to hold at 33% even as revenue rises, with material, labor and manufacturing costs continuing to climb against a largely fixed cost base and no long-term supplier contracts.
- The three stated headwinds — high fab utilization, high memory costs and geopolitics — persist into fiscal 2027 while planned CapEx carries over, delaying the expansion revenue they were meant to produce.
- A parent-level borrowing decision signals the cash held inside the joint ventures is not freely accessible, or an adverse currency move or adverse litigation development adds pressure.
Looking Ahead
The next twelve months turn on whether Q4 revenue lands inside the widened band and whether the expansion program converts on the timelines management has repeated. Allen is targeted for initial revenue in the quarter just reported, with its geographic contribution reflected in fiscal 2027; Korea is on track to deliver 8-nanometer capabilities over the next 1.5 years, with initial revenue by the end of fiscal 2027. December's fiscal Q4 earnings release carries FY2027 CapEx guidance, the cleanest test of whether the fiscal 2026 cut was timing or scope. EUV remains an option the company has deliberately not funded, and high-end FPD demand is expected to continue through fiscal Q4 and beyond.
- Q4 FY2026Q4 results in December — Revenue must land inside the widened Q4 band.
- Q4 FY2026Allen first revenue — Initial U.S. revenue targeted for the quarter just reported.
- DecemberFY2027 CapEx guidance — Shows whether the FY2026 cut was timing or scope.
- Later this calendar yearG8.6 AMOLED broadening — Additional orders expected from a growing customer base.
- Quarters aheadEUV strategy update — Management says it hopes to report more "in quarters to come."
- End of fiscal 2027Korea initial revenue — 8-nanometer expansion revenue targeted by end FY2027.
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $867M | $849M | $867M | -2.0% |
| Gross Margin | 36.4% | 35.3% | 33.7% | 112bps |
| EBITDA | $304M | $286M | $274M | -6.0% |
| EBITDA Margin | 35.1% | 33.7% | 31.6% | 142bps |
| Net Income | $131M | $136M | $165M | +4.4% |
| Free Cash Flow | $131M | $60M | $110M | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)33.7%
- EBITDA Margin (TTM)31.6%
- Net Margin (TTM)19.0%
- ROIC25.2%
- FCF Conversion40.3%
- SBC / Revenue1.6%
The Company
Photronics manufactures photomasks: high-precision photographic quartz or glass plates carrying microscopic images of electronic circuits, used to fabricate integrated circuits and flat panel displays. The mask is the master template from which a chip's or a panel's layers are printed, so every new design and every new node requires a fresh set. That makes the company an embedded supplier to leading-edge work rather than a seller of AI systems. The best disclosed proxy for its AI-linked business is high-end IC, which was about 32% of Q3 FY2026 total revenue (44% of IC), up from about 27% in Q2 — a figure that also includes non-AI leading-edge work. Management ties the exposure to specific assets: the Boise, Idaho facility is qualified to produce masks at the 7-nanometer node, Taiwan and U.S. facilities are positioned for advanced chip packaging, and the company supplies EUV R&D masks through partnerships.
The company reports as a single segment and, per its FY2025 10-K, runs eleven manufacturing facilities in Taiwan, China, South Korea, the United States and Europe, four of which are named: Brookfield, Connecticut; Cheonan, South Korea; and Hsinchu and Taichung in Taiwan. It holds 50.01% ownership interests in joint ventures, and $504M of its $673M of cash and short-term investments sits inside those ventures, so parent-level liquidity is smaller than the headline. Operations are shaped by two mechanics: demand tracks customer design releases rather than wafer starts, and backlog is very short — no more than one to two weeks for IC photomasks and two to three weeks for FPD. The cost base is largely fixed, which management has said leaves few levers when demand softens and amplifies the drop-through when it recovers.
Business Segments
Competitive Landscape
The FY2025 10-K names a set of merchant photomask competitors, and the competitive dynamic splits by market. In the mainstream, management describes the China market as competitive, with local mask houses focused on that segment; the company's response has been to concentrate on the high end, where it cites technology leadership and a competitive advantage. In the United States, management says it wants to be the main photomask supplier, and the Allen expansion is the vehicle. The structural wrinkle is that the largest chipmakers run captive mask shops of their own, so they appear as both potential competitors and customers — the basis for management's captive-outsourcing opportunity. One competitor entry, Dai Nippon Printing, is qualified as competing outside Taiwan and China.
- Dai Nippon Printing Co., Ltd.Named in the 10-K competitor list but qualified as competing "outside of Taiwan and China." The intel file identifies the DNP joint venture PDMCX as the likely source of the disclosed related-party revenue (inferred, not disclosed).
- Hoya CorporationNamed in the 10-K competitor list; not discussed.
- Taiwan Mask CorporationNamed in the 10-K competitor list; not discussed.
- Shenzhen Newway Photomask Making Co., Ltd.Named in the 10-K competitor list; management describes unnamed local Chinese mask houses as competitors focused on the mainstream.
- Tekscend PhotomaskNamed in the 10-K competitor list; the intel file flags the unfamiliar name as a possible consolidation or rebrand signal on the supply side (inferred).
Supply Chain
Photronics buys quartz blanks, pellicles, electronic-grade chemicals and mask-writing and inspection tools, and sells finished photomasks to chipmakers and display makers — some of which make masks in-house. No neighbor company in the evidence pack mentions Photronics by name.
Related companies
See all Chip Making companies → · How this layer works: Chapter 1, The Chip →
More on PLAB: Earnings recap